BioAffinity Technologies (BIAF) said Thursday it named J. Michael Edwards as chief financial officer, effective Nov. 5.
The biotechnology company said Edwards has been serving as interim CFO since Sept. 15 and previously was the company's consulting CFO from 2014 to 2023. He also oversaw BioAffinity's initial public offering in 2022, the company said.
BIAF shares were down 4.5% in recent trading.
Price: 1.90, Change: -0.09, Percent Change: -4.52
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments